For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 7 results
Author Title Type [ Year(Desc)]
Filters: Author is Jeng, Philip J  [Clear All Filters]
2018
Murphy SM, McCollister KE, Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR.  2018.  Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.. Ann Intern Med.
2019
Schackman BR, Jeng PJ, Flash MJE, Mejia M, Oksuzyan S, Scott JA, Freedberg KA, Kulkarni SP, Garland WH.  2019.  Cost of an HIV Medical Care Coordination Program in Los Angeles County.. J Acquir Immune Defic Syndr. 81(1):e15-e17.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.  2019.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Carlo AD, Jeng PJ, Bao Y, Unützer J.  2019.  The Learning Curve After Implementation of Collaborative Care in a State Mental Health Integration Program.. Psychiatr Serv. 70(2):139-142.
Wen H, Hockenberry JM, Jeng PJ, Bao Y.  2019.  Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.. Health Aff (Millwood). 38(9):1550-1556.
Murphy SM, Morgan JR, Jeng PJ, Schackman BR.  2019.  Will converting naloxone to over-the-counter status increase pharmacy sales? Health Serv Res. 54(4):764-772.
2020
Wen K, Johnson P, Jeng PJ, Schackman BR, Bao Y.  2020.  State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital Events.. Med Care.